SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

眼科機器市場規模、シェア、業界分析および予測　2024-2032年

Ophthalmic Devices Market Size, Share, Growth and Global Industry Analysis

眼科機器市場 : タイプと用途、地域別の市場規模、シェア、業界分析および予測　2024-2032年
Ophthalmic Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

商品番号 : SMB-77959

出版社Fortune Business Insights
出版年月2025年5月
ページ数150
価格タイプシングルユーザライセンス
価格USD 4,850
種別英文調査報告書

北米は2024年に世界市場の42.92%を占め、最大の市場シェアを獲得しました。この優位性は、先進的な眼科技術の急速な導入と、この地域における有力な市場プレーヤーの存在に起因しています。この地域の強固な医療インフラと眼の健康に対する高い意識が、この地域の主導的な地位に貢献しています。

Growth Factors of Ophthalmic Devices Market

The global ophthalmic devices market is poised for steady growth, driven by increasing vision disorders, technological advancements, and a growing geriatric population. According to Fortune Business Insights, the market was valued at USD 30.08 billion in 2024 and is projected to reach USD 43.77 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.8% during the forecast period.

世界の眼科機器市場は、視覚障害の増加、技術の進歩、そして高齢化人口の増加を背景に、着実な成長が見込まれています。Fortune Business Insightsによると、市場規模は2024年に300億8000万米ドルと評価され、2032年には437億7000万米ドルに達すると予測されており、予測期間中の年平均成長率（CAGR）は4.8%となります。

Market Drivers

The rising prevalence of vision disorders such as myopia, glaucoma, and cataracts is a significant driver. A joint report by the World Health Organization (WHO) and the Brien Holden Vision Institute in 2015 projected that by 2050, myopia and high myopia could affect 52% and 10% of the global population, respectively. This surge underscores the need for advanced ophthalmic devices for diagnosis and treatment.

Technological advancements are also propelling market growth. Innovations in intraocular lenses, diagnostic tools, and surgical equipment have enhanced the effectiveness of treatments and surgeries. For instance, the development of advanced intraocular lenses has improved outcomes for cataract surgeries, which are among the most common ophthalmic procedures.

Additionally, the increasing number of eye surgeries, such as cataract operations, is boosting demand for surgical ophthalmic devices. In 2018, approximately 3.9 million cataract surgeries were performed in the U.S. alone, indicating a substantial demand for surgical ophthalmic devices.

Market Segmentation

The ophthalmic devices market is segmented by product and end user.

  • By Product:

o               Surgical Devices: Includes implants, consumables, and equipment used in procedures like cataract and glaucoma surgeries.

o               Vision Care Products: Encompasses contact lenses and ocular health products aimed at correcting vision impairments.

  • By End User:

o             Hospitals: Major centers for ophthalmic surgeries and treatments.

o               Ophthalmic Clinics: Specialized facilities focusing on eye care services.

o               Others: Includes ambulatory surgical centers and academic institutes.

Regional Insights

North America held the largest market share in 2024, accounting for 42.92% of the global market. This dominance is attributed to the rapid adoption of advanced ophthalmic technologies and the presence of leading market players in the region. The region’s robust healthcare infrastructure and high awareness about eye health contribute to its leading position.

Impact of COVID-19

The COVID-19 pandemic led to a significant decline in ophthalmic surgical procedures, affecting the sales of related devices. An analysis of approximately 228 hospitals in the U.S. revealed an 81% decrease in patient visits for ophthalmology during March and April 2020 compared to the same period in 2019. This decline impacted the revenues of companies operating in the ophthalmic devices market.

Leading Market Players

Prominent companies in the ophthalmic devices market include:

  • Alcon
  • Johnson & Johnson Vision Care, Inc.
  • Bausch & Lomb Incorporated
  • The Cooper Companies

These companies are actively engaged in research and development to introduce innovative products and expand their market presence. For instance, in January 2018, Hoya Corporation launched a new R&D facility in Singapore focused on developing technologically advanced intraocular lenses. Such initiatives are expected to provide significant opportunities for market growth.

Conclusion

The global ophthalmic devices market is set to experience steady growth, driven by the increasing prevalence of vision disorders, technological advancements, and a growing elderly population. While the COVID-19 pandemic posed challenges, the market is expected to recover and continue its upward trajectory, supported by ongoing innovations and rising demand for

ATTRIBUTE        DETAILS

Study Period          2019-2032

Base Year               2024

Forecast Period     2025-2032

Historical Period  2019-2023

Unit        Value (USD billion)

Segmentation        By Product Type

  • Surgical

o               Implants

o               Consumables

o               Equipment

  • Vision Care

o               Contact Lens

o               Ocular Health

By End-user

  • Hospitals
  • Ophthalmic Clinics
  • Others

By Geography

  • North America

o               By Product

o               By End User

o               By Country

  • Europe

o               By Product

o               By End User

o               By Country/Sub-region

  • Asia Pacific

o               By Product

o               By End User

o               By Country/Sub-region

  • Latin America

o               By Product

o               By End User

o               By Country/Sub-region

  • The Middle East & Africa

o               By Product

o               By End User

o               By Country/Sub-region

Table of Contents

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Key Industry Developments – Mergers, Acquisitions, and Partnerships, 2024
4.2. Epidemiology of Major Ocular Disease – For Key Countries
4.3. Introduction of New Products / Approvals (by Major Players)
4.4. Overview of Regulatory Scenario – Key Countries
4.5. Technological Advancements in Ophthalmic Devices Market
5. Global Ophthalmic Devices Market Analysis, Insights and Forecast, 2019-2032
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product Type
5.2.1. Surgical
5.2.1.1. Implants
5.2.1.2. Consumables
5.2.1.3. Equipment
5.2.2. Vision Care
5.2.2.1. Contact Lenses
5.2.2.2. Intraocular Lenses
5.3. Market Analysis, Insights and Forecast – By End-user
5.3.1. Hospitals
5.3.2. Ophthalmic Clinics
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Ophthalmic Devices Market Analysis, Insights and Forecast, 2019-2032
6.1. Key Findings / Summary
6.2. Market Analysis – By Product Type
6.2.1. Surgical
6.2.1.1. Implants
6.2.1.2. Consumables
6.2.1.3. Equipment
6.2.2. Vision Care
6.2.2.1. Contact Lenses
6.2.2.2. Intraocular Lenses
6.3. Market Analysis – By End-user
6.3.1. Hospitals
6.3.2. Ophthalmic Clinics
6.3.3. Others
6.4. Market Analysis – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Ophthalmic Devices Market Analysis, Insights and Forecast, 2019-2032
7.1. Key Findings / Summary
7.2. Market Analysis – By Product Type
7.2.1. Surgical
7.2.1.1. Implants
7.2.1.2. Consumables
7.2.1.3. Equipment
7.2.2. Vision Care
7.2.2.1. Contact Lenses
7.2.2.2. Intraocular Lenses
7.3. Market Analysis – By End-user
7.3.1. Hospitals
7.3.2. Ophthalmic Clinics
7.3.3. Others
7.4. Market Analysis – By Country/ Sub-region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Spain
7.4.5. Italy
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific Ophthalmic Devices Market Analysis, Insights and Forecast, 2019-2032
8.1. Key Findings / Summary
8.2. Market Analysis – By Product Type
8.2.1. Surgical
8.2.1.1. Implants
8.2.1.2. Consumables
8.2.1.3. Equipment
8.2.2. Vision Care
8.2.2.1. Contact Lenses
8.2.2.2. Intraocular Lenses
8.3. Market Analysis – By End-user
8.3.1. Hospitals
8.3.2. Ophthalmic Clinics
8.3.3. Others
8.4. Market Analysis – By Country/ Sub-region
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Latin America Ophthalmic Devices Market Analysis, Insights and Forecast, 2019-2032
9.1. Key Findings / Summary
9.2. Market Analysis – By Product Type
9.2.1. Surgical
9.2.1.1. Implants
9.2.1.2. Consumables
9.2.1.3. Equipment
9.2.2. Vision Care
9.2.2.1. Contact Lenses
9.2.2.2. Intraocular Lenses
9.3. Market Analysis – By End-user
9.3.1. Hospitals
9.3.2. Ophthalmic Clinics
9.3.3. Others
9.4. Market Analysis – By Country/ Sub-region
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
10. Middle East & Africa Ophthalmic Devices Market Analysis, Insights and Forecast, 2019-2032
10.1. Key Findings / Summary
10.2. Market Analysis – By Product Type
10.2.1. Surgical
10.2.1.1. Implants
10.2.1.2. Consumables
10.2.1.3. Equipment
10.2.2. Vision Care
10.2.2.1. Contact Lenses
10.2.2.2. Intraocular Lenses
10.3. Market Analysis – By End-user
10.3.1. Hospitals
10.3.2. Ophthalmic Clinics
10.3.3. Others
10.4. Market Analysis – By Country/ Sub-region
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2019)
11.3. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.3.1. Alcon (Part of Novartis AG)
11.3.1.1. Overview,
11.3.1.2. Products,
11.3.1.3. SWOT analysis,
11.3.1.4. Recent developments,
11.3.1.5. strategies,
11.3.1.6. financials (based on availability)
11.3.2. Johnson & Johnson Services, Inc.
11.3.2.1. Overview,
11.3.2.2. Products,
11.3.2.3. SWOT analysis,
11.3.2.4. Recent developments,
11.3.2.5. strategies,
11.3.2.6. financials (based on availability
11.3.3. Essilor
11.3.3.1. Overview,
11.3.3.2. Products,
11.3.3.3. SWOT analysis,
11.3.3.4. Recent developments,
11.3.3.5. strategies,
11.3.3.6. financials (based on availability
11.3.4. Bausch Health Companies
11.3.4.1. Overview,
11.3.4.2. Products,
11.3.4.3. SWOT analysis,
11.3.4.4. Recent developments,
11.3.4.5. strategies,
11.3.4.6. financials (based on availability
11.3.5. ZEISS International
11.3.5.1. Overview,
11.3.5.2. Products,
11.3.5.3. SWOT analysis,
11.3.5.4. Recent developments,
11.3.5.5. strategies,
11.3.5.6. financials (based on availability
11.3.6. HOYA
11.3.6.1. Overview,
11.3.6.2. Products,
11.3.6.3. SWOT analysis,
11.3.6.4. Recent developments,
11.3.6.5. strategies,
11.3.6.6. financials (based on availability
11.3.7. NIDEK CO., LTD
11.3.7.1. Overview,
11.3.7.2. Products,
11.3.7.3. SWOT analysis,
11.3.7.4. Recent developments,
11.3.7.5. strategies,
11.3.7.6. financials (based on availability
11.3.8. TOPCON
11.3.8.1. Overview,
11.3.8.2. Products,
11.3.8.3. SWOT analysis,
11.3.8.4. Recent developments,
11.3.8.5. strategies,
11.3.8.6. financials (based on availability
11.3.9. CooperVision
11.3.9.1. Overview,
11.3.9.2. Products,
11.3.9.3. SWOT analysis,
11.3.9.4. Recent developments,
11.3.9.5. strategies,
11.3.9.6. financials (based on availability
11.3.10. Other Prominent Players
11.3.10.1. Overview,
11.3.10.2. Products,
11.3.10.3. SWOT analysis,
11.3.10.4. Recent developments,
11.3.10.5. strategies,
11.3.10.6. financials (based on availability

医療・医薬の最新記事8件